Here's the live share price of OneSource Specialty Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| OneSource Specialty Pharma | 4.97 | 16.18 | 4.97 | -12.52 | 5.89 | -1.76 | -1.06 |
| Sun Pharmaceutical Industries | -1.60 | -4.94 | 2.15 | -1.15 | -4.45 | 19.46 | 21.13 |
| Divi's Laboratories | 1.47 | 4.25 | 3.21 | -4.48 | 5.94 | 25.21 | 10.79 |
| Torrent Pharmaceuticals | -1.62 | -2.97 | 1.61 | 13.04 | 26.00 | 36.11 | 25.98 |
| Lupin | -1.68 | 0.12 | 6.23 | 18.55 | 12.37 | 48.52 | 16.73 |
| Dr. Reddy's Laboratories | -0.14 | -2.87 | -0.05 | -4.94 | 3.55 | 8.18 | 3.19 |
| Cipla | 0.68 | 1.01 | -9.96 | -24.94 | -19.18 | 11.00 | 5.51 |
| Zydus Lifesciences | -0.85 | 7.84 | 4.88 | -7.92 | 8.86 | 21.51 | 10.94 |
| Mankind Pharma | 5.24 | 16.20 | 4.01 | -8.79 | -13.27 | 16.19 | 9.42 |
| Aurobindo Pharma | 3.14 | 10.90 | 23.84 | 29.10 | 19.41 | 34.00 | 7.40 |
| Alkem Laboratories | 0.52 | 8.93 | -2.78 | 1.36 | 11.81 | 17.77 | 14.90 |
| Glenmark Pharmaceuticals | -1.02 | 7.17 | 12.08 | 20.93 | 60.93 | 62.98 | 31.57 |
| Laurus Labs | -1.52 | 14.40 | 9.46 | 17.43 | 68.80 | 54.52 | 19.40 |
| Biocon | 2.05 | -2.64 | -4.03 | -1.30 | 7.10 | 16.61 | -2.19 |
| Abbott India | -1.99 | -0.07 | -8.10 | -15.43 | -17.86 | 4.16 | 11.02 |
| Anthem Biosciences | 3.65 | 20.25 | 24.42 | 5.22 | 3.48 | 1.15 | 0.69 |
| GlaxoSmithKline Pharmaceuticals | 2.73 | 8.43 | 3.87 | -10.42 | -11.98 | 25.40 | 11.15 |
| Ipca Laboratories | 1.51 | -2.54 | 0.55 | 17.27 | 3.43 | 21.86 | 7.29 |
| Ajanta Pharma | -3.36 | -0.34 | 2.73 | 15.51 | 3.99 | 29.50 | 18.01 |
| J B Chemicals & Pharmaceuticals | -0.10 | -5.13 | 3.96 | 15.77 | 19.37 | 23.65 | 24.21 |
Over the last one year, OneSource Specialty Pharma has gained 5.89% compared to peers like Sun Pharmaceutical Industries (-4.45%), Divi's Laboratories (5.94%), Torrent Pharmaceuticals (26.00%). From a 5 year perspective, OneSource Specialty Pharma has underperformed peers relative to Sun Pharmaceutical Industries (21.13%) and Divi's Laboratories (10.79%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,535.04 | 1,519.01 |
| 10 | 1,460.95 | 1,487.08 |
| 20 | 1,441.84 | 1,456.68 |
| 50 | 1,368.92 | 1,441.3 |
| 100 | 1,495.67 | 1,498.62 |
| 200 | 1,686.91 | 1,574.04 |
In the latest quarter, OneSource Specialty Pharma saw a rise in promoter holding to 30.50%, while DII stake increased to 20.61%, FII holding fell to 17.50%, and public shareholding moved down to 31.40% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 36,28,016 | 3.82 | 534.52 | |
| 12,21,228 | 4.53 | 179.92 | |
| 9,16,559 | 0.56 | 135.04 | |
| 6,49,672 | 0.84 | 95.72 | |
| 6,20,302 | 0.78 | 91.39 | |
| 5,44,509 | 2.91 | 80.22 | |
| 4,85,952 | 0.31 | 71.6 | |
| 4,69,095 | 0.34 | 69.11 | |
| 4,40,404 | 1.15 | 64.88 | |
| 3,98,475 | 1.13 | 58.71 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Apr 21, 2026, 01:50 PM IST IST | OneSource Specialty - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Apr 18, 2026, 01:01 AM IST IST | OneSource Specialty - Intimation Of "Renewal Of EU -GMP Certification For Onesource : Flagship Unit II Facility |
| Apr 16, 2026, 03:44 PM IST IST | OneSource Specialty - Intimation Of ESG Rating |
| Apr 10, 2026, 01:28 AM IST IST | OneSource Specialty - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Mar 07, 2026, 12:34 AM IST IST | OneSource Specialty - Update On Composite Scheme Of Arrangement |
OneSource Specialty Pharma Ltd. is a Public Limited Listed company incorporated on 12/06/2007 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U74140MH2007PLC432497 and registration number is 432497. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1299.59 Cr. and Equity Capital is Rs. 11.44 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for OneSource Specialty Pharma is ₹1,614.10 as on Apr 22, 2026.
The OneSource Specialty Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of OneSource Specialty Pharma is ₹18,504.47 Cr as on Apr 22, 2026.
Today’s highest and lowest price of OneSource Specialty Pharma are ₹1,622.90 and ₹1,554.25.
The 52-week high/low is the highest and lowest price at which OneSource Specialty Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of OneSource Specialty Pharma is ₹2,249.65 and 52-week low of OneSource Specialty Pharma is ₹1,075.00 as on Apr 22, 2026.
The OneSource Specialty Pharma has shown returns of 3.4% over the past day, 16.18% for the past month, 4.97% over 3 months, 5.89% over 1 year, -1.76% across 3 years, and -1.06% over 5 years.
P/E ratio of and PB ratio of OneSource Specialty Pharma are 920.55 and 3.18 on Apr 22, 2026. While the company gives a dividend yield of 0.00 per annum.